- Acoramidis demonstrated a significant reduction in risk of CVM through 42 months post-randomization, with a 44% hazard reduction, setting a new standard for CVM outcomes for patients with ATTR-CM - ...

PALO ALTO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, ...

Attruby is a transthyretin stabilizer indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death ...

First, create a new instance of the Label widget. Second, place the Label on the main window by calling the pack() method. If you don’t call the pack() function, the program still creates the label ...

In this tutorial, we’ll explore how to create and customize a Tkinter window in Python. You’ll learn how to change the window’s title, resize it, set transparency, modify the stacking order, and even ...

From pioneering inventions to scientific and medical advancements, the History Channel website lists antibiotics among the 11 innovations that shaped the course of human history, noting its use spread ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

In the phase 3 randomized controlled study ATTRibute-CM (Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy), acoramidis, a transthyretin stabilizer, demonstrated ...